Another study based on osteosarcoma reported that qRT-PCR analysis on miR-214-3p as well as PTEN expressions after treatment with formononetin was examined, and the results show the miR-214-3p level was noticeably reduced and PTEN level was evidently improved by formononetin treatment [40] (Table 1). This evidence concerns the gene PTEN and osteosarcoma.